MedTrace Logo

RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy

NCT00564915 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 145

Last updated 2007-11-29

No results posted yet for this study

Summary

A study of the efficacy and tolerability of two different ketogenic diets in children with drug resistant epilepsy; children resistant to at least two drugs randomised to reveive diet after baseline or after further 3m control period; in addition randomised to either MCT or classical ketogenic diet.

Conditions

Interventions

DIETARY_SUPPLEMENT

Ketogenic diet

Ketogenic diet

Sponsors & Collaborators

  • Institute of Child Health

    lead OTHER

Principal Investigators

  • Helen Cross, Professor · UCL Institute of Child Health

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-12-31
Completion
2006-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00564915 on ClinicalTrials.gov